DocGo (DCGO) announced an expanded partnership with SHL Telemedicine (SHLT) to integrate the SmartHeart portable 12-lead ECG device across DocGo mobile health care units. This expanded collaboration, initially launched in the New York-New Jersey area, will now bring advanced cardiovascular diagnostics to patients' homes and underserved communities in additional markets across the country. According to the Journal of the American College of Cardiology, 46% of U.S. counties do not have any cardiologists1, highlighting the urgent need for accessible cardiovascular care. SHL Telemedicine's SmartHeart , a cutting-edge ECG device enabling high-quality 12-lead ECG performance anytime and anywhere, enhances patient care by eliminating the need for traditional clinic visits for essential cardiovascular screenings. With cardiologist-reviewed results available promptly, this innovation improves patient outcomes, especially for those in areas lacking cardiologists or access to healthcare facilities. This helps to eliminate many of the traditional obstacles that have discouraged people from engaging with cardiovascular healthcare providers. ...The first phase of this partnership expansion will focus on California, where DocGo is actively addressing healthcare access challenges in underserved areas. By equipping mobile health vehicles with SmartHeart technology, DocGo will provide critical cardiovascular diagnostics to rural communities and healthcare deserts.